David Dworaczyk is the founder of Bryn Pharma. Bryn Pharma has raised $9M in total funding. Backed by RezVen Partners. Based in Raleigh, N.C., USA.
David Dworaczyk is the CEO of Bryn Pharma, a privately held pharmaceutical company dedicated to developing alternative treatments for anaphylaxis. He co-founded the company with the goal of providing an easy-to-use, needle-free, and convenient solution for patients at risk of anaphylaxis.
Full founder directory · Investor directory · Company funding database · Fundraising library